• 1
    Bleul CC,Fuhlbrigge RC,Casasnovas JM,Aiuti A,Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996; 184: 11011109.
  • 2
    Cabioglu N,Sahin A,Doucet M, et al. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis. 2005; 22: 3946.
  • 3
    Kang H,Watkins G,Douglas-Jones A,Mansel RE,Jiang WG. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast. 2005; 14: 360367.
  • 4
    Tabe Y,Konopleva M,Munsell MF, et al. PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood. 2004; 103: 18151822.
  • 5
    Crazzolara R,Kreczy A,Mann G, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol. 2001; 115: 545553.
  • 6
    Rombouts EJ,Pavic B,Lowenberg B,Ploemacher RE. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood. 2004; 104: 550557.
  • 7
    Spoo AC,Lubbert M,Wierda WG,Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood. 2007; 109: 786791.
  • 8
    Onciu M,Schlette E,Medeiros LJ,Abruzzo LV,Keating M,Lai R. Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. Am J Clin Pathol. 2001; 116: 886892.
  • 9
    Chen W,Jones D,Medeiros LJ,Luthra R,Lin P. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type. Br J Haematol. 2005; 130: 726728.
  • 10
    Georgakis GV,Li Y,Rassidakis GZ,Martinez-Valdez H,Medeiros LJ,Younes A. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Clin Cancer Res. 2006; 12: 584590.
  • 11
    Hesselgesser J,Liang M,Hoxie J, et al. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol. 1998; 160: 877883.
  • 12
    Estey EH,Pierce S,Keating MJ. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities. Haematologica. 2000; 85: 246249.
  • 13
    Fukuda S,Broxmeyer HE,Pelus LM. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. Blood. 2005; 105: 31173126.
  • 14
    Estey EH,Shen Y,Thall PF. Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB. Blood. 2000; 95: 7277.